Literature DB >> 20699363

Magnetic resonance metabolomics of intact tissue: a biotechnological tool in cancer diagnostics and treatment evaluation.

Tone F Bathen1, Beathe Sitter, Torill E Sjøbakk, May-Britt Tessem, Ingrid S Gribbestad.   

Abstract

Personalized medicine is increasingly important in cancer treatment for its role in staging and its potential to improve stratification of patients. Different types of molecules, genes, proteins, and metabolites are being extensively explored as potential biomarkers. This review discusses the major findings and potential of tissue metabolites determined by high-resolution magic angle spinning magnetic resonance spectroscopy for cancer detection, characterization, and treatment monitoring.

Entities:  

Mesh：

Year:  2010        PMID： 20699363     DOI： 10.1158/0008-5472.CAN-10-0437

Source DB:  PubMed          Journal:  Cancer Res        ISSN： 0008-5472            Impact factor:   12.701


  44 in total

1.  MetSign: a computational platform for high-resolution mass spectrometry-based metabolomics.

Authors:  Xiaoli Wei; Wenlong Sun; Xue Shi; Imhoi Koo; Bing Wang; Jun Zhang; Xinmin Yin; Yunan Tang; Bogdan Bogdanov; Seongho Kim; Zhanxiang Zhou; Craig McClain; Xiang Zhang
Journal:  Anal Chem       Date:  2011-09-20       Impact factor: 6.986

Review 2.  Stable isotope-resolved metabolomics and applications for drug development.

Authors:  Teresa W-M Fan; Pawel K Lorkiewicz; Katherine Sellers; Hunter N B Moseley; Richard M Higashi; Andrew N Lane
Journal:  Pharmacol Ther       Date:  2011-12-23       Impact factor: 12.310

Review 3.  Personalized radiotherapy: concepts, biomarkers and trial design.

Authors:  A H Ree; K R Redalen
Journal:  Br J Radiol       Date:  2015-05-20       Impact factor: 3.039

4.  Influence of androgen deprivation therapy on choline PET/CT in recurrent prostate cancer.

Authors:  Rutger J Dost; Andor W J M Glaudemans; Anthonius J Breeuwsma; Igle J de Jong
Journal:  Eur J Nucl Med Mol Imaging       Date:  2013-04-06       Impact factor: 9.236

Review 5.  Metabolomics: a novel approach to identify potential diagnostic biomarkers and pathogenesis in Alzheimer's disease.

Authors:  Xu-Hua Xu; Yue Huang; Gang Wang; Sheng-Di Chen
Journal:  Neurosci Bull       Date:  2012-10-03       Impact factor: 5.203

6.  Clinical applications of breast cancer metabolomics using high-resolution magic angle spinning proton magnetic resonance spectroscopy (HRMAS 1H MRS): systematic scoping review.

Authors:  Almir G V Bitencourt; Johanna Goldberg; Katja Pinker; Sunitha B Thakur
Journal:  Metabolomics       Date:  2019-11-06       Impact factor: 4.290

Review 7.  Focus on the glycerophosphocholine pathway in choline phospholipid metabolism of cancer.

Authors:  Kanchan Sonkar; Vinay Ayyappan; Caitlin M Tressler; Oluwatobi Adelaja; Ruoqing Cai; Menglin Cheng; Kristine Glunde
Journal:  NMR Biomed       Date:  2019-06-11       Impact factor: 4.044

8.  2-hydroxyglutarate as a magnetic resonance biomarker for glioma subtyping.

Authors:  Morteza Esmaeili; Riyas Vettukattil; Tone Frost Bathen
Journal:  Transl Oncol       Date:  2013-04-01       Impact factor: 4.243

9.  Plasma metabolomic profiles predict near-term death among individuals with lower extremity peripheral arterial disease.

Authors:  Chiang-Ching Huang; Mary M McDermott; Kiang Liu; Ching-Hua Kuo; San-Yuan Wang; Huimin Tao; Yufeng Jane Tseng
Journal:  J Vasc Surg       Date:  2013-05-17       Impact factor: 4.268

10.  Structural mass spectrometry of tissue extracts to distinguish cancerous and non-cancerous breast diseases.

Authors:  Kelly M Hines; Billy R Ballard; Dana R Marshall; John A McLean
Journal:  Mol Biosyst       Date:  2014-11
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.